John Gram is Founder and President of J.T. Gram & Associates, Inc. (JTG&A).
John spent over 20 years in the biopharma industry primarily in roles pertaining to market analytics, marketing, and business development and licensing. He was Director and Franchise Leader, Life Sciences at SmartAnalyst, a global strategic decision support consulting firm. Before that, John led the Decision Support group for Biogen Idec with responsibility for Rituxan®. Prior to that, John was Vice-President of Marketing and Business Development at Novavax, a development stage biopharmaceutical company focused in cancer, women’s health, and vaccines.
Before Novavax, he was with Amgen, where he led the team responsible for the information needs of the oncology business unit with responsibility for Aranesp®, Neulasta®, and Neupogen®. John began his biopharmaceutical career with Ligand Pharmaceuticals and helped successfully launch four oncology products, Targretin® oral and topical, Ontak®, and Panretin® gel. John spent the first fourteen years of his career in market research with the A.C. Nielsen Company in the consumer packaged goods industry.
John holds a Bachelor of Science degree, from Providence College, and received his Masters in Business Administration from the University of San Diego.
Executive Healthcare Program, Tuck School of Business, Dartmouth College; M.B.A., Finance and Marketing, University of San Diego; B.S., Providence College.
Call Us: (760) 842-1895 or Email: email@example.com